Adequan Ships, Remains Limited
Adequan® IM and IA are the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the treatment of non-infectious degenerative and / or traumatic joint dysfunction and associated lameness in horses....
Read More
Adequan Expected to Hit Market in Late August
Adequan may hit the shelves much earlier than originally expected. Luitpold Animal Health announced a revised target date of late August for the re-release of the company's products to the market....
Read More